Survivorship Promotion In Reducing IGF-1 Trial

NCT02431676 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Prostate Cancer
Lung Cancer
Colon Cancer
Melanoma of Skin
Endometrial Cancer
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Kidney Cancer
Other Solid Malignant Tumors

Interventions

DRUG: Metformin
BEHAVIORAL: Coach Directed Behavioral Weight Loss
BEHAVIORAL: Self-control weight loss

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]